Jayempi Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - rechazo del injerto - inmunosupresores - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Dapagliflozin Viatris Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogas usadas en diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 y 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Certifect Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

certifect

merial - fipronil, amitraz, (s)-methoprene - ectoparasiticides para uso tópico, incl. los insecticidas - perros - tratamiento y prevención de las infestaciones en los perros por las garrapatas (ixodes ricinus, dermacentor reticulatus, rhipicephalus sanguineus, ixodes scapularis, dermacentor variabilis, haemaphysalis elliptica, haemaphysalis longicornis, amblyomma americanum y amblyomma maculatum) y las pulgas (ctenocephalides felis y ctenocephalides canis). tratamiento de infestaciones por piojos masticadores (trichodectes canis). prevención de la contaminación ambiental por pulgas al inhibir el desarrollo de todas las etapas inmaduras de las pulgas. el producto puede usarse como parte de una estrategia de tratamiento para el control de la dermatitis alérgica a las pulgas. eliminación de pulgas y garrapatas dentro de las 24 horas. un tratamiento previene infestaciones adicionales durante cinco semanas por garrapatas y hasta por cinco semanas por pulgas. el tratamiento indirectamente reduce el riesgo de transmisión de enfermedades transmitidas por garrapatas (canina de la babesiosis, ehrlichiosis monocítica, anaplasmosis granulocítica y borreliosis) de garrapatas infectadas durante cuatro semanas.

Coxevac Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

coxevac

ceva santé animale - vacuna inactivada de coxiella burnetii, cepa nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Econor Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

econor

elanco gmbh - valnemulin - antiinfectives para uso sistémico - pigs; rabbits - pigsthe de prevención y tratamiento de la disentería porcina. el tratamiento de los signos clínicos de la enteropatía proliferativa porcina (ileítis). la prevención de los signos clínicos de la espiroquetosis colónica porcina (colitis) cuando la enfermedad ha sido diagnosticada en el rebaño. tratamiento y prevención de la neumonía enzoótica porcina. con la dosis recomendada de 10-12 mg / kg de peso corporal, las lesiones pulmonares y la pérdida de peso se reducen, pero la infección con mycoplasma hyopneumoniae no se elimina. rabbitsreduction de mortalidad durante un brote de epizoótica del conejo enteropatía (ere). el tratamiento debe iniciarse temprano en el brote, cuando el primer conejo ha sido diagnosticado con la enfermedad clínicamente.

Improvac Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

improvac

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - inmunológicos para suidos - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. otro factor clave para la contaminación del verraco, el escatol, también se puede reducir como un efecto indirecto. los comportamientos agresivos y sexuales (de montaje) también se reducen. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Metacam Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

metacam

boehringer ingelheim vetmedica gmbh - meloxicam - oxicams - horses; dogs; cattle; cats; pigs; guinea pigs - gatos:alivio de leve a moderado dolor post-operatorio y la inflamación después de procedimientos quirúrgicos, e. ortopédica y de tejidos blandos cirugía. el alivio del dolor y de la inflamación aguda y crónica de los trastornos musculoesqueléticos. reducción del dolor post-operatorio después de la ovariohisterectomía y menor de tejidos blandos cirugía. cattle:for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. para uso en diarrea en combinación con terapia de rehidratación oral para reducir los signos clínicos en terneros de más de una semana de edad y ganado joven no lactante. para el alivio del dolor postoperatorio después del descorne en terneros. para la terapia adyuvante en el tratamiento de la mastitis aguda, en combinación con la terapia con antibióticos. dogs:alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. reducción del dolor postoperatorio y la inflamación después de la cirugía ortopédica y de tejidos blandos. horses:for use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders. para el alivio del dolor asociado con el cólico equino. el alivio de la inflamación y el alivio del dolor agudo y crónico de los trastornos musculoesqueléticos. cerdos: para uso en la no-infecciosas, trastornos del aparato locomotor para reducir los síntomas de cojera e inflamación. para el alivio del dolor post-operatorio asociados con el menor de los tejidos blandos de la cirugía, tales como la castración. para la terapia adyuvante en el tratamiento de la septicemia y toxemia puerperal (síndrome de mastitis-metritis-agalactia) con la terapia antibiótica adecuada. los conejillos de indias:alivio de leve a moderado dolor post-operatorio asociados con los tejidos blandos de la cirugía, tales como la castración masculina.